Navigation Links
Cholesterol Drugs May Slow MS
Date:4/16/2010

Fewer brain lesions developed in patients taking Lipitor than placebo, researchers say

FRIDAY, April 16 (HealthDay News) -- Cholesterol-lowering statin drugs may slow the progression of multiple sclerosis, according to a new study.

It included 81 patients with early-stage MS randomly selected to take either 80 milligrams a day of Lipitor (atorvastatin) or a placebo. After 12 months of treatment, 55.3 percent of patients taking the drug had developed no new brain lesions, compared with 27.6 percent of those who took the placebo.

The results of the phase II, multi-center trial were presented Wednesday at the annual scientific meeting of the American Academy of Neurology. Lipitor, placebo and additional support were provided by Pfizer, Inc., which makes Lipitor.

"Our data is preliminary, and we need a larger study to confirm the effects of the drug and their magnitude," study co-leader Dr. Emmanuelle Waubant, an associate professor of neurology at the MS Center at the University of California, San Francisco, said in a news release.

"It is important that we understand how statins impact the progression of multiple sclerosis in order to better inform physicians and patients of their effect since these drugs are so broadly used throughout the United States and the world, and to learn whether a relatively inexpensive oral therapy can slow the course of the disease," he added.

MS is an autoimmune disease in which immune cells attack the central nervous system and destroy the protective sheath (myelin) that surrounds nerves. This results in scars or lesions in demyelinated areas of the brain and spinal cord.

More information

The U.S. National Institute of Neurological Disorders and Stroke has more about multiple sclerosis.




'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. Menopause Often Means Worsening Cholesterol
2. QuickMedial Praises New Study Linking High Cholesterol Levels to Increased Risk for Developing Alzheimer's Disease or Vascular Dementia
3. Cholesterol-Lowering Drug Shows Promise Against Serious Infections in Sickle Cell Disease
4. Cholesterol-lowering drugs also may protect stem cell transplant patients from GVHD
5. Normal Cholesterol Doesnt Guarantee Healthy Heart
6. Low cholesterol transfer protein activity associated with heart disease risk
7. Latest epidemic? High cholesterol, obesity in fruit flies
8. Myrrh May Lower High Cholesterol
9. Eating Your Way to Low Cholesterol: How I Lowered My Cholesterol Without Drugs
10. A common cholesterol drug fights cataracts, too
11. Teamwork Unlikely to Improve Cholesterol Levels
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... With the FCPX LUT Soft pack from ... LUT is a Lookup Table that contains a mathematical formula for modifying an image. The ... comes with 60 soft CUBE LUT files. , FCPX LUT Soft requires Final Cut ...
(Date:8/31/2015)... ... August 31, 2015 , ... Diablo Publications (DP), ... it has officially launched a new website and company identity ( diablopublications.com) . ... more closely aligned with the company’s strategic vision for growth and expansion over ...
(Date:8/31/2015)... ... August 31, 2015 , ... Dad Phil, ... ribbon-cutting ceremony on Aug. 26, generously hosted by the Collinsville Chamber of Commerce, ... AdvantaClean’s National Call Center and website since Aug. 17. , The Greens have ...
(Date:8/31/2015)... ... August 31, 2015 , ... Physicians’ ... Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® meeting, is seeking ... 6 in New York City. The annual legacy meeting uses a variety of ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... be at a greater risk for injury, potentially because they are more susceptible ... Pittsburgh Graduate School of Public Health analysis discovered. , The research, published ...
Breaking Medicine News(10 mins):Health News:Pixel Film Studios, FCPX Plugin Developer, Releases FCPX LUT Soft 2Health News:Diablo Publications Launches New Company Website 2Health News:Diablo Publications Launches New Company Website 3Health News:Ribbon Cutting Launches AdvantaClean of Madison County 2Health News:Physicians’ Education Resource® Seeks Abstracts for the Upcoming Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® 2Health News:Physicians’ Education Resource® Seeks Abstracts for the Upcoming Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® 3Health News:Physicians’ Education Resource® Seeks Abstracts for the Upcoming Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® 4Health News:Television Viewing Linked to Higher Injury Risk in Hostile People 2Health News:Television Viewing Linked to Higher Injury Risk in Hostile People 3
... states neglect preventing tobacco-caused illness , , TUESDAY, Jan. 13 ... U.S. government consistently failing grades for not protecting Americans ... American Lung Association,s State of Tobacco Control 2008 ... failed to enact critical policy measures, such as higher ...
... Weather Compound January,s Blood Drain NEW YORK, Jan. 13 ... operations (serving New York City, Long Island, Hudson Valley ... blood donations. Hospital demand for blood (needed for ... while levels of blood donation have been below forecast. ...
... General Practitioners (GPs) can delegate visits to patients and ... can provide care to more patients. Neeltje van den ... the "AGnES" project in the current edition of ... 2009; 106[1-2]: 3-9). , The change in the age ...
... Inc. today announced the,formation and launch of its newest ... to offer experienced and affordable custom,website design and marketing ... area. , Dr. Nino Doijashvilli, ... found a definite need for this service. Many ...
... Health announced today that the National Children,s Study will ... study of how genes and the environment interact to ... announced that the first phase of recruitment for the ... Queens, New York. The study will track ...
... 2009) The American Journal of Nursing ... publications of 2008 with an announcement today of its ... separate categories appear in the journal,s January issue. ... controversial consumer health topics and nursing industry issues that ...
Cached Medicine News:Health News:U.S. Flunks on Tobacco Control Report Card 2Health News:U.S. Flunks on Tobacco Control Report Card 3Health News:U.S. Flunks on Tobacco Control Report Card 4Health News:Blood Emergency: Blood Supply Tips Into Danger Zone 2Health News:Blood Emergency: Blood Supply Tips Into Danger Zone 3Health News:Blood Emergency: Blood Supply Tips Into Danger Zone 4Health News:Blood Emergency: Blood Supply Tips Into Danger Zone 5Health News:Tulip Systems Launches New Division: Atlanta Medical Websites 2Health News:National Children's Study Begins Recruiting Volunteers 2Health News:National Children's Study Begins Recruiting Volunteers 3Health News:National Children's Study Begins Recruiting Volunteers 4Health News:National Children's Study Begins Recruiting Volunteers 5Health News:American Journal of Nursing announces 2008 Book of the Year Awards 2
(Date:8/31/2015)...   BioLife Solutions , Inc. (NASDAQ: ... of proprietary clinical grade cell and tissue ... media and a related cloud hosted biologistics ... shippers ("BioLife" or the "Company"), today announced ... company focused on developing and commercializing novel therapeutics ...
(Date:8/29/2015)... 2015 La sofisticada aplicación ... sistemas de imagen por Ultrasonidos   ofrece resultados más ... rápidos y un flujo de trabajo   optimizado, lo ... proceso de detección de Cardiopatías   ... el lanzamiento europeo de HeartModel A.I ...
(Date:8/28/2015)... , August 28, 2015 ... Market by Tumor (Breast, Lung, Prostate) Type (Protein & ... (Diagnostic, Drug Discovery, Prognostic) & Geography - Global Forecast ... is expected to reach around 17,689.0 Million USD by ... period of 2015 to 2020. Browse ...
Breaking Medicine Technology:BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 2BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 3BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 4BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 5Philips presenta HeartModel A.I en el Congreso ESC 2015 2Philips presenta HeartModel A.I en el Congreso ESC 2015 3Philips presenta HeartModel A.I en el Congreso ESC 2015 4Philips presenta HeartModel A.I en el Congreso ESC 2015 5Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 2Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 3Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 4Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 5
... MacroChem Corporation (OTC,Bulletin Board: MACM) today announced results ... who completed a 48-week, U.S. multi-center,open-label efficacy and ... the treatment of onychomycosis (nail fungus). The composite,primary ... defined as,negative mycology (negative fungal culture and negative ...
... Sound Pharmaceuticals (SPI) has filed,an Investigational New ... of a proprietary formulation of ebselen for the ... oral capsule,containing ebselen, SPI-3005, will be tested in ... patients receiving platinum based chemotherapy.,This marks the second ...
Cached Medicine Technology:MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 2MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 3MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 4MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 5Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer 2
... (PTH) is synthesized by the parathyroid ... to decreased extracellular calcium concentrations. PTH ... and decreasing calcium excretion by the ... intact PTH is rapidly degraded into ...
ACTIVATED CLOTTING TIME SYSTEM...
... Erythropoietin (EPO) is the primary known ... The predicted molecular weight of human EPO ... circulating form of EPO has an estimated ... itself appears to have a unique structure, ...
... versatility. Positron Corporation is the exclusive distributor ... whole body PET scanners. This unique performance ... quality images in clinical oncology, cardiology, and ... only scanner on the market that is ...
Medicine Products: